XML 156 R44.htm IDEA: XBRL DOCUMENT v3.25.1
ORGANIZATION AND NATURE OF BUSINESS (Details) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2023
Mar. 31, 2025
Mar. 31, 2024
Dec. 31, 2023
Dec. 31, 2024
Dec. 31, 2023
Net Loss   $ (818,097) $ (1,866,690)   $ (16,183,018) $ (18,542,654)
CANA Pharmaceutical Laboratories, S.A. ("Cana") [Member]            
Cash         5,331,120  
Fair value of common stock issued $ 138,667       138,667  
Fair value of total consideration transferred         5,469,787  
Inventory         297,340  
Property, plant and equipment         7,488,818  
Identifiable intangible assets         562,200  
Financial liabilities         (3,235,233)  
Total identifiable net assets         6,910,036  
Bargain purchase gain         $ 1,440,249  
Revenue       $ 344,708    
Net Loss       $ (1,232,732)